BridgeBio Pharma, Inc. <BBIO.O>: TD Cowen raises target price to $110 from $95
BBIO•Related News
Francisco Partners to buy Moneris for about C$2 billion from BMO and RBC
BMO•
Equitable Holdings Inc <EQH.N>: KBW Raises Target Price to $67 From $62
EQH•
AB InBev flags BlackRock beneficial stake at 3.11% voting rights
BUD•
Middle East deadlock
SPY•
Bausch + Lomb director Andrew C. von Eschenbach sells 18,559 common shares for $306,709.22
BLCO•